Ion Channel Modulators - Global Strategic Business Report - 2013-2018

Research and Markets logo

Dublin, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Research and Markets ( has announced the addition of the "Ion Channel Modulators - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Ion Channel Modulators in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

The report profiles 48 ion channel modulators companies including many key and niche players such as AstraZeneca, Aurora Biomed, Inc., CalciMedica, Inc., Cellectricon AB, Convergence Pharmaceuticals Limited, Cytocentrics AG, Evotec AG, flyion GmbH, GlaxoSmithKline Plc, Neusentis, Inc., Nanion Technologies GmbH, NeuroSearch A/S, Novartis AG, Parion Sciences, Inc., Pfizer, Inc., Sanofi, Targacept, Inc., Xention Limited, and Zalicus, Inc. Microsoft Corporation, QNX Software Systems Ltd., Renesas Electronics Corporation, VIA Technologies, Inc., and Zilog, Inc.

Key Topics Covered:

I. Introduction, Methodology & Product Definitions

II. Executive Summary

1. Industry Overview

2. Product Overview

3. Product Launches/Introductions

4. Recent Industry Activity

5. Focus On Select Global Players

6. Global Market Perspective

III. Market

1. The United States

2. Canada

3. Japan

4. Europe

5. Asia-Pacific

6. Latin America

7. Rest Of World

IV. Competitive Landscape
Total Companies Profiled: 48 (including Divisions/Subsidiaries - 50)

  • The United States (19)
  • Canada (1)
  • Japan (2)
  • Europe (26)
  • - France (2)
  • - Germany (6)
  • - The United Kingdom (9)
  • - Italy (2)
  • - Rest of Europe (7)
  • Asia-Pacific (Excluding Japan) (2)

For more information visit

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Source:Research and Markets